<p>Kaplan-Meier survival plots stratified according to genotypes of rs13419896 are shown. Difference in overall survival across genotypic groups of NSCLC patients was examined using the log-rank test with <i>P</i>-values as indicated.</p
<p>The differences between the groups were statistically significant (p = 0.017 in the derivation gr...
<p><b>Note:</b></p>a<p>The log-rank <i>p</i> value was derived from the Kaplan–Meier method using th...
<p><i>P</i> values were determined by the log-rank test. (A) Distant recurrence-free survival, (B) d...
<p>Kaplan-Meier survival curve for male advanced NSCLC patients by <i>BCL2</i> rs1564483 G>A genotyp...
<p>Kaplan-Meier survival analysis of CDCS cohort stratified by rs6922269 genotype a) in patients wit...
<p>Kaplan-Meier survival analysis of CDCS cohort patients stratified by rs6922269 genotype.</p
<p>Note:</p>a<p>The log-rank <i>p</i> value was derived from the Kaplan-Meier method using the log-r...
<p>(A) Squamous cell carcinoma group, (B) ever smokers group, (C) ECOG performance status = 1 group...
<p>Shown are survival curves for groups of NSCLC patients with the lowest and highest tumor expressi...
a<p>Adjusted for age, sex, smoking status, diabetes mellitus, histology, clinical stage, surgical op...
<p>(A) Genetic variant within microRNA-126 is not associated with survival times. Kaplan-Meier survi...
<p>Kaplan-Meier curves of overall survival of lung cancer patients with different genotypes at intro...
<p>Survival curves for each genotypic class are plotted based on the multivariate Cox proportional m...
<p>Abbreviations: MST, median survival time; HR, hazard ratio.</p><p>Note: The frequency of rs156448...
<p>Disease-free survival (A) and Overall survival (B) for low NPAA and high NPAA patients. P values ...
<p>The differences between the groups were statistically significant (p = 0.017 in the derivation gr...
<p><b>Note:</b></p>a<p>The log-rank <i>p</i> value was derived from the Kaplan–Meier method using th...
<p><i>P</i> values were determined by the log-rank test. (A) Distant recurrence-free survival, (B) d...
<p>Kaplan-Meier survival curve for male advanced NSCLC patients by <i>BCL2</i> rs1564483 G>A genotyp...
<p>Kaplan-Meier survival analysis of CDCS cohort stratified by rs6922269 genotype a) in patients wit...
<p>Kaplan-Meier survival analysis of CDCS cohort patients stratified by rs6922269 genotype.</p
<p>Note:</p>a<p>The log-rank <i>p</i> value was derived from the Kaplan-Meier method using the log-r...
<p>(A) Squamous cell carcinoma group, (B) ever smokers group, (C) ECOG performance status = 1 group...
<p>Shown are survival curves for groups of NSCLC patients with the lowest and highest tumor expressi...
a<p>Adjusted for age, sex, smoking status, diabetes mellitus, histology, clinical stage, surgical op...
<p>(A) Genetic variant within microRNA-126 is not associated with survival times. Kaplan-Meier survi...
<p>Kaplan-Meier curves of overall survival of lung cancer patients with different genotypes at intro...
<p>Survival curves for each genotypic class are plotted based on the multivariate Cox proportional m...
<p>Abbreviations: MST, median survival time; HR, hazard ratio.</p><p>Note: The frequency of rs156448...
<p>Disease-free survival (A) and Overall survival (B) for low NPAA and high NPAA patients. P values ...
<p>The differences between the groups were statistically significant (p = 0.017 in the derivation gr...
<p><b>Note:</b></p>a<p>The log-rank <i>p</i> value was derived from the Kaplan–Meier method using th...
<p><i>P</i> values were determined by the log-rank test. (A) Distant recurrence-free survival, (B) d...